221 research outputs found

    Non-stoichiometric amorphous magnesium-iron silicates in circumstellar dust shells. Dust growth in outflows from supergiants

    Full text link
    We investigate the dust growth in oxygen-rich stellar outflows for a set of nine well-observed massive supergiants with optically thin dust shells. Models of the infrared emission from their circumstellar dust shells are compared to their observed infrared spectra so as to derive the essential parameters that govern dust formation in the extended envelope of these stars. The results obtained from the comparative study are also compared with the predictions of a model for silicate dust condensation solely based on laboratory data and basic stellar properties. The infrared emission in the wavelength range between 6 and 25 mu can be reproduced rather well by a mixture of non-stoichiometric iron-bearing silicates, alumina, and metallic iron dust particles for all nine objects. The observed spectra obtained from three objects, mu Cep, RW Cyg, and RS Per, can be reproduced by a stationary and (essentially) spherically symmetric outflow which enables a direct comparison with predictions from a theoretical dust growth model. The temperature at the onset of massive silicate dust growth is of the order of 920 K and the corresponding outflow velocity of the order of the sound velocity for these objects. The condensation temperature suggests that the silicate dust grows on the corundum dust grains that are formed well in the interior of the silicate dust shell at a much higher temperature. Our results propose that regarding the two major problems of dust formation in stellar outflows: (i) formation of seed nuclei; (ii) their growth to macroscopic dust grains, we are gradually coming close to a quantitative understanding of the second item.Comment: 29 pages, 9 figures, accepted by Astronomy & Astrophysic

    A new two-variable generalization of the chromatic polynomial

    Get PDF
    We present a two-variable polynomial, which simultaneously generalizes the chromatic polynomial, the independence polynomial, and the matching polynomial of a graph. This new polynomial satisfies both an edge decomposition formula and a vertex decomposition formula. We establish two general expressions for this new polynomial: one in terms of the broken circuit complex and one in terms of the lattice of forbidden colorings. We show that the new polynomial may be considered as a specialization of Stanley's chromatic symmetric function. We finally give explicit expressions for the generalized chromatic polynomial of complete graphs, complete bipartite graphs, paths, and cycles, and show that it can be computed in polynomial time for trees and graphs of restricted pathwidth

    Does competition improve hospital performance:a DEA based evaluation from the Netherlands

    Get PDF
    Many countries have introduced competition among hospitals aiming to improve their performance. We evaluate the introduction of competition among hospitals in the Netherlands over the years 2008–2015. The analysis is based on a unique longitudinal data set covering all Dutch hospitals and health insurers, as well as demographic and geographic data. We measure hospital performance using Data Envelopment Analysis and distinguish three components of competition: the fraction of freely negotiated services, market power of hospitals, and insurer bargaining power. We present new methods to define variables for each of these components which are more accurate than previously developed measures. In a multivariate regression analysis, the variables explain more than half of the variance in hospital efficiency. The results indicate that competition between hospitals and the relative fraction of freely negotiable health services are positively related to hospital efficiency. At the same time, the policy measure to steadily increase the fraction of health services contracted in competition may well have resulted in a decrease in hospital efficiency. The models show no significant association between insurer bargaining power and hospital efficiency. Altogether, the results offer little evidence that the introduction of competition for hospital care in the Netherlands has been effective

    Financial risk allocation and provider incentives in hospital–insurer contracts in The Netherlands

    Get PDF
    In healthcare systems with a purchaser–provider split, contracts are an important tool to define the conditions for the provision of healthcare services. Financial risk allocation can be used in contracts as a mechanism to influence provider behavior and stimulate providers to provide efficient and high-quality care. In this paper, we provide new insights into financial risk allocation between insurers and hospitals in a changing contracting environment. We used unique nationwide data from 901 hospital–insurer contracts in The Netherlands over the years 2013, 2016, and 2018. Based on descriptive and regression analyses, we find that hospitals were exposed to more financial risk over time, although this increase was somewhat counteracted by an increasing use of risk-mitigating measures between 2016 and 2018. It is likely that this trend was heavily influenced by national cost control agreements. In addition, alternative payment models to incentivize value-based health care were rarely used and thus seemingly of lower priority, despite national policies being explicitly directed at this goal. Finally, our analysis shows that hospital and insurer market power were both negatively associated with financial risk for hospitals. This effect becomes stronger if both hospital and insurer have strong market power, which in this case may indicate a greater need to reduce (financial) uncertainties and to create more cooperative relationships.</p

    Nanosized Multifunctional Polyplexes for Receptor-Mediated SiRNA Delivery

    Get PDF
    Although our understanding of RNAi and our knowledge on designing and synthesizing active and safe siRNAs significantly increased during the past decade, targeted delivery remains the major limitation in the development of siRNA therapeutics. On one hand, practical considerations dictate robust chemistry reproducibly providing precise carrier molecules. On the other hand, the multistep delivery process requires dynamic multifunctional carriers of substantial complexity. We present a monodisperse and multifunctional carrier system, synthesized by solid phase supported chemistry, for siRNA delivery in vitro and in vivo. The sequence-defined assembly includes a precise cationic (oligoethanamino)amide core, terminated at the ends by two cysteines for bioreversible polyplex stabilization, at a defined central position attached to a monodisperse polyethylene glycol chain coupled to a terminal folic acid as cell targeting ligand. Complexation with an endosomolytic influenza peptide-siRNA conjugate results in nanosized functional polyplexes of 6 nm hydrodynamic diameter. The necessity of each functional substructure of the carrier system for a specific and efficient gene silencing was confirmed. The nanosized polyplexes showed stability in vivo, receptor-specific cell targeting, and silencing of the EG5 gene in receptor-positive tumors. The nanosized appearance of these particles can be precisely controlled by the oligomer design (from 5.8 to 8.8 nm diameter). A complete surface charge shielding together with the high stability result in good tolerability in vivo and the absence of accumulation in nontargeted tissues such as liver, lung, or spleen. Due to their small size, siRNA polyplexes are efficiently cleared by the kidney

    Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure

    Get PDF
    INTRODUCTION: Most case series suggest that less than half of the patients receiving a mechanical cardiac assist device as a bridge to recovery due to severe post-cardiotomy heart failure survive to hospital discharge. Levosimendan is the only inotropic substance known to improve medium term survival in patients suffering from severe heart failure. METHODS: This retrospective analysis covers our single centre experience. Between July 2000 and December 2004, 41 consecutive patients were treated for this complication. Of these, 38 patients are included in this retrospective analysis as 3 patients died in the operating room. Levosimendan was added to the treatment protocol for the last nine patients. RESULTS: Of 29 patients treated without levosimendan, 20 could be weaned off the device, 9 survived to intensive care unit discharge, 7 left hospital alive and 3 survived 180 days. All 9 patients treated with levosimendan could be weaned, 8 were discharged alive from ICU and hospital, and 7 lived 180 days after surgery (p < 0.002 for 180 day survival). Plasma lactate after explantation of the device was significantly lower (p = 0.002), as were epinephrine doses. Time spent on renal replacement therapy was significantly shorter (p = 0.023). CONCLUSION: Levosimendan seems to improve medium term survival in patients failing to wean off cardiopulmonary bypass and requiring cardiac assist devices as a bridge to recovery. This retrospective analysis justifies prospective randomised investigations of levosimendan in this group of patients

    Disordered Electrons in a Strong Magnetic Field: Transfer Matrix Approaches to the Statistics of the Local Density of States

    Full text link
    We present two novel approaches to establish the local density of states as an order parameter field for the Anderson transition problem. We first demonstrate for 2D quantum Hall systems the validity of conformal scaling relations which are characteristic of order parameter fields. Second we show the equivalence between the critical statistics of eigenvectors of the Hamiltonian and of the transfer matrix, respectively. Based on this equivalence we obtain the order parameter exponent α0≈3.4\alpha_0\approx 3.4 for 3D quantum Hall systems.Comment: 4 pages, 3 Postscript figures, corrected scale in Fig.

    Are Tall People Less Risk Averse than Others?

    Full text link
    This paper examines the question of whether risk aversion of prime-age workers is negatively correlated with human height to a statistically significant degree. A variety of estimation methods, tests and specifications yield robust results that permit one to answer this question in the affirmative. Hausman-Taylor panel estimates, however, reveal that height effects disappear if personality traits and skills, parents' behaviour, and interactions between environment and individual abilities appear simultaneously. Height is a good proxy for these influences if they are not observable. Not only one factor but a combination of several traits and interaction effects can describe the time-invariant individual effect in a panel model of risk attitude
    • …
    corecore